The recent decision by the NIH to implement significant cuts to funding for biomedical research has raised alarms across the scientific community. Researchers have expressed concerns that these cuts, which total billions and include slashing support for indirect research costs, will jeopardize medical progress and threaten the infrastructure of research institutions nationwide. Universities such as Pitt are expected to face severe reductions in federal research money, leading to widespread outcry from higher education leaders who warn of dire consequences for scientific advancement. Critics including Senator Murray have condemned these funding cuts as indiscriminate measures that could set back lifesaving research efforts. As the NIH lowers its indirect cost rate to 15%, the long-term impacts on the U.S. dominance in medical research remain uncertain, with many fearing that these drastic changes represent a catastrophic blow to the foundation of scientific inquiry.